MiNK Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
INKT Company Description
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
INKT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view INKT Smart Score
Score Breakdown
INKT Company Description
Show More
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of INKT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by INKT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of INKT in WallStreetBets Daily Discussion
INKT News
Recent insights relating to INKT
CNBC Recommendations
Recent picks made for INKT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in INKT
Corporate Flights
Flights by private jets registered to INKT
Our Analysis